The Evolution of Neuroendoscopy Guided by Head-mounted Mixed Reality Technique Navigation System in Neurosurgery
Launched by SHANGHAI ZHONGSHAN HOSPITAL · Jul 22, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the way surgeons remove tumors located in the pineal region and brainstem, which are tricky areas in the brain. The trial is testing a new system that uses mixed reality technology—think of it like wearing special glasses that help doctors see detailed images of the brain during surgery. The goal is to see if this technology can help surgeons remove more of the tumor while also reducing the risk of serious complications and making surgeries quicker.
To participate in this trial, patients should be between 18 and 70 years old and need to have a strong preoperative health status (meaning they should be functioning well before surgery). It’s important that candidates don’t have a history of certain other health problems or previous treatments that might complicate surgery. If eligible, participants can expect to be part of a study that aims to enhance surgical outcomes and improve their overall experience during treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Preoperative suspicion of pineal region and brainstem tumors;
- • 2. Age range from 18 to 70 years old;
- • 3. Preoperative neurological function was good, with KPS\>70 points;
- • 4. Informed consent of patients and their families;
- Exclusion Criteria:
- • 1. Recurrent pineal region and brainstem tumors, previously received radiation therapy;
- • 2. Combined with serious cardiovascular disease, other systemic malignancies, and other diseases;
- • 3. Participants who participate in clinical trials of other drugs or devices but fail to achieve the main research endpoint;
- • 4. The subjects are unable or unwilling to participate in this experiment
- • 5. Preoperative discussion considers that patients are unable to undergo neurosurgical endoscopic surgery and require the use of microscopy or other techniques to assist in tumor resection;
About Shanghai Zhongshan Hospital
Shanghai Zhongshan Hospital is a prestigious medical institution affiliated with Fudan University, renowned for its commitment to advancing healthcare through rigorous clinical research and innovative patient care. With a focus on multidisciplinary collaboration and cutting-edge medical technologies, the hospital conducts a wide range of clinical trials aimed at improving treatment outcomes across various specialties. Its state-of-the-art facilities and highly qualified research team ensure that trials adhere to the highest ethical and scientific standards, contributing significantly to the global body of medical knowledge and enhancing patient health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported